| 1. |
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380: 2095-2128.
|
| 2. |
Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ, 2022, 378: e069679.
|
| 3. |
Soriano JB, Kendrick PJ, Paulson KR, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med, 2020, 8: 585-596.
|
| 4. |
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392: 1736-1788.
|
| 5. |
Chronic obstructive pulmonary disease (COPD) [EB/OL]. WHO, 2025. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
|
| 6. |
Health data overview for the People’s Republic of China [EB/OL]. WHO, 2025. https://data.who.int/countries/156.
|
| 7. |
Palliative care [EB/OL]. WHO, 2025. https://www.who.int/news-room/fact-sheets/detail/palliative-care.
|
| 8. |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 2018, 391: 1706-1717.
|
| 9. |
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of COPD: 2025 Report [EB/OL]. 2025. https://goldcopd.org/.
|
| 10. |
Wagner V, Marks A. What is hospice? JAMA, 2024, 332: 1218.
|
| 11. |
Quinn KL, Shurrab M, Gitau K, et al. Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: a systematic review and meta-analysis. JAMA, 2020, 324: 1439-1450.
|
| 12. |
Baltaji S, Cheronis N, Bajwa O, et al. The role of palliative care in COPD. Crit Care Nurs Q, 2021, 44: 113-120.
|
| 13. |
Mir WAY, Siddiqui AH, Paul V, et al. Palliative care and chronic obstructive pulmonary disease (COPD) readmissions: a narrative review. Cureus, 2021, 13: e16987.
|
| 14. |
Bra?o Forte C, Sousa S. End of life in COPD patients: time for a change. Breathe (Sheff), 2017, 13: e84-e86.
|
| 15. |
Hospice Friendly Hospitals: Draft Quality Standards for End-of-Life Care in Hospice [S]. Irish Hospice Foundation, Dublin, 2009.
|
| 16. |
Tatum PE, Mills SS. Hospice and palliative care: an overview. Med Clin North Am, 2020, 104: 359-373.
|
| 17. |
路桂軍, 姜姍, 李忠, 等. 安寧療護服務對象準入標準的國際經驗與中國實踐. 醫學與哲學, 2021, 42: 28-31.
|
| 18. |
周玲君, 崔靜, Bee Wee, 等. 我國臨終關懷準入標準界定的質性研究. 中華現代護理雜志, 2010, 16: 1245-1248.
|
| 19. |
Chinese Expert Consensus Working Group on the Definition of Palliative Care. Chinese expert consensus on the definitions of palliative care and hospice care (2025). Chin Med Sci J, 2025, 40: 89-99.
|
| 20. |
吳瓊, 郭秀君, 李狀雙, 等. 慢性阻塞性肺疾病急性加重期中醫臨床護理路徑的構建. 護理研究, 2019, 33: 3107-3112.
|
| 21. |
郝潔, 喬麗娟, 黃惠濤, 等. 基于德爾菲法和層次分析法構建醫院藥師工作滿意度量表. 中國醫院藥學雜志, 2021, 41: 200-206.
|
| 22. |
陳皓然, 吳秋惠, 彭宇竹, 等. 慢性阻塞性肺疾病藥物治療管理培訓體系的構建. 藥學服務與研究, 2021, 21: 332-337.
|
| 23. |
劉爽, 姜丹, 趙榮生. 基于德爾菲法確定霉酚酸治療藥物監測指南的臨床問題與結局指標. 中國醫院藥學雜志, 2022, 42: 1479-1482.
|
| 24. |
張若彬, 吳秋惠, 曹馨瑞, 等. 基于德爾菲法構建藥師視角下慢性阻塞性肺疾病患者分級管理標準. 藥師與藥學服務, 2024, 35: 860-865.
|
| 25. |
王芳, 蔡英華, 許正紅, 等. 慢性阻塞性肺疾病個案管理師準入標準體系的構建. 護理研究, 2021, 35: 411-416.
|
| 26. |
孫文, 李珍, 陳佳林, 等. 基于德爾菲法的突發重大傳染病社區韌性評價指標體系. 公共衛生與預防醫學, 2025, 36: 6-11.
|
| 27. |
文富強, 陳磊. 中國慢性阻塞性肺疾病診療的現存問題與思考. 中華醫學雜志, 2020, 100: 81-84.
|
| 28. |
蹇在金. 現代老年醫學理念 1234. 中華老年醫學雜志, 2016, 35: 805-807.
|
| 29. |
Le Rouzic O, Roche N, Cortot AB, et al. Defining the "frequent exacerbator" phenotype in COPD: a hypothesis-free approach. Chest, 2018, 153: 1106-1115.
|
| 30. |
Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998, 157: 1418-1422.
|
| 31. |
Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2017, 195: 324-330.
|
| 32. |
Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest, 2003, 124: 459-467.
|
| 33. |
李書嬌, 郭園潤, 王明哲, 等. 664 例慢性阻塞性肺疾病急性加重老年患者 3 年生存狀況及中西醫預后影響因素. 北京中醫藥大學學報, 2024, 47: 1288-1296.
|
| 34. |
Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration, 2012, 84: 17-26.
|
| 35. |
林澤輝, 許銀姬. 慢性阻塞性肺疾病急性加重患者住院死亡結局預測模型研究. 臨床肺科雜志, 2020, 25: 1175-1179.
|
| 36. |
吳哲, 董萬里, 李克芳, 等. AECOPD 并呼吸衰竭患者預后相關因素分析及預測模型構建. 醫藥論壇雜志, 2025, 46: 253-259.
|
| 37. |
Peng L, Yi Q, Luo Y, et al. Derivation and validation of a new score for predicting in-hospital mortality in exacerbations of chronic obstructive pulmonary disease. J Gen Intern Med, 2025, 40(13): 3068-3077.
|